Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Taking the sex out of sexual health screening

09.05.2008
Young women would accept age-based screening for the sexually transmitted infection chlamydia, but would want this test to be offered to everyone, rather than to people ‘singled out’ according to their sexual history.

In the study, published in the BioMed Central open access journal BMC Infectious Diseases, the Australian women interviewed did not like discussing their sex lives with their GPs. Some said they would even lie about how many sexual partners they had had if asked. In response to these findings, the study authors suggest that a detailed sexual history should not be required before testing women for chlamydia.

Chlamydia is Australia’s and the UK’s most commonly diagnosed sexually transmitted infection (STI). It is most prevalent in the under-25s and can have serious long-term health consequences, including causing infertility in women.

A team comprising three doctors, a sociologist and an epidemiologist at the University of Melbourne, Australia aimed to find out what young Australian women thought about the introduction of chlamydia screening into general practice. The researchers interviewed 24 sexually active women aged 16 to 24 who attended one of a sample of general practices. Equal numbers of women from rural, regional and urban areas were questioned.

In contrast to previous research, which suggests women are not concerned about giving information about their sexual history in the context of a family planning or sexual health clinic, interviewees were reluctant to provide such a history to their GPs. This is a new finding which raises the question of whether a sexual history is really necessary when screening for chlamydia.

The authors acknowledge that it is important for young women to understand that chlamydia is an STI and that sexual partners should be notified if someone tests positive. However, they said that chlamydia testing should be destigmatised. “In general practice the offer [of a chlamydia test] may seem to come ‘out of the blue’” says Natasha Pavlin, who coordinated the study. “The importance of normalising the offer of chlamydia testing, so that individual women do not feel singled out, cannot be overemphasised.”

Charlotte Webber | alfa
Further information:
http://www.biomedcentral.com/bmcinfectdis/
http://www.biomedcentral.com

More articles from Studies and Analyses:

nachricht Some brain tumors may respond to immunotherapy, new study suggests
11.12.2018 | Columbia University Irving Medical Center

nachricht Climate change and air pollution damaging health and causing millions of premature deaths
30.11.2018 | International Institute for Applied Systems Analysis (IIASA)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>